Why the study?
The study evaluated the relationship between baseline AF-related quality of life and 12-month improvement in perceived symptoms and general health across predefined age categories.
Does baseline quality of life (AFEQT score) predict improvement in EHRA score at 12 months in patients with de novo atrial fibrillation?
Population
483 patients diagnosed with AF de novo across four hospitals
Comparison
Baseline AFEQT score quartiles stratified by age categories
Design
Prospective cohort study
Follow-up
12 months
Authors
Loading...
Low baseline AFEQT was associated with greater EHRA improvement; hypothesis-generating for QoL-based stratification in de novo AF.
Does baseline quality of life (AFEQT score) predict improvement in EHRA score at 12 months in patients with de novo atrial fibrillation?
Patients with newly diagnosed atrial fibrillation and lower baseline quality of life are more likely to experience symptom improvement at 12 months, particularly those aged 65-74 years.
Cremers et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: